Lenti-IAV TCR (Cysteine-modiﬁed)-VP(VP-TCR-C199)
The ready-to-use lentiviral particles of Lenti-IAV TCR (Cysteine-modiﬁed)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Human TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
Type of Therapeutics
T cell receptor
The Orthomyxoviruses are a family of RNA viruses that includes six genera: Influenza virus A, Influenza
virus B, Influenza virus C, Isavirus, Thogotovirus and Quaranjavirus. Influenza A and C infect multiple
species, while influenza B almost exclusively infects humans. The first three genera contain viruses
that cause influenza in vertebrates, including birds (see also avian influenza), humans, and other
mammals. Isaviruses infect salmon; thogotoviruses infect vertebrates and invertebrates, such as
mosquitoes and sea lice.
LMP2; EBNA3A nuclear protein; EBNA3A; TCR; T cell receptor; transgenic TCR; antigen-specific T cell receptors; Engineering T-cell receptors; recombinant t cell receptors; specific t cell receptor; modified t cell receptor; retroviral vector; Hodgkin's Disease and Nasopharyngeal Carcinoma
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.